Updated vaccines by Pfizer (NYSE:PFE)/BioNTech (NASDAQ ... or older get the updated vaccine if they haven’t gotten a booster recently. The FDA is also in the process of reviewing an updated ...
The updated adjuvanted ... For mRNA vaccines, such as Pfizer-BioNTech and Moderna, booster doses are recommended based on evidence showing increased immunity post-booster, which is considered ...
Thinking about getting a spring-time booster shot? A new study coming out of York ... Immunity Task-Force project for more ...
Vaccine availability is on a first-come, first-served basis and while supplies last. Updated bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines and boosters will be available at the clinics. The ...
People who got the COVID-19 booster had stronger protection against the virus that causes the disease compared to people who ...
Thinking about getting a spring-time booster shot? A new study coming out of York University’s Centre for Disease Modelling in the Faculty of Science shows that immunity after a COVID-19 booster lasts ...
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.
Representatives for Pfizer and BioNTech did not immediately respond to requests for comment. Moderna accused Pfizer and BioNTech's vaccine of violating its patent rights in messenger-RNA ...
The EMA has previously OK'ed vaccines made by Pfizer-BioNTech and Moderna for use in ... of age and older who have received an initial booster" of any approved Covid jab, Moderna said on Twitter.
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna ...